CareDx Total Liabilities 2013-2023 | CDNA
CareDx total liabilities from 2013 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
| CareDx Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $205 |
| 2022 | $112 |
| 2021 | $101 |
| 2020 | $91 |
| 2019 | $53 |
| 2018 | $35 |
| 2017 | $90 |
| 2016 | $57 |
| 2015 | $26 |
| 2014 | $20 |
| 2013 | $25 |
| 2012 | $22 |
| CareDx Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2023-12-31 | $205 |
| 2023-09-30 | $107 |
| 2023-06-30 | $110 |
| 2023-03-31 | $108 |
| 2022-12-31 | $112 |
| 2022-09-30 | $108 |
| 2022-06-30 | $98 |
| 2022-03-31 | $89 |
| 2021-12-31 | $101 |
| 2021-09-30 | $91 |
| 2021-06-30 | $78 |
| 2021-03-31 | $70 |
| 2020-12-31 | $91 |
| 2020-09-30 | $85 |
| 2020-06-30 | $84 |
| 2020-03-31 | $55 |
| 2019-12-31 | $53 |
| 2019-09-30 | $47 |
| 2019-06-30 | $50 |
| 2019-03-31 | $32 |
| 2018-12-31 | $35 |
| 2018-09-30 | $47 |
| 2018-06-30 | $51 |
| 2018-03-31 | $46 |
| 2017-12-31 | $90 |
| 2017-09-30 | $75 |
| 2017-06-30 | $66 |
| 2017-03-31 | $65 |
| 2016-12-31 | $57 |
| 2016-09-30 | $65 |
| 2016-06-30 | $68 |
| 2016-03-31 | $28 |
| 2015-12-31 | $26 |
| 2015-09-30 | $25 |
| 2015-06-30 | $25 |
| 2015-03-31 | $24 |
| 2014-12-31 | $20 |
| 2014-09-30 | $22 |
| 2014-06-30 | $35 |
| 2014-03-31 | $28 |
| 2013-12-31 | $25 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.480B | $0.280B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.161B | 15.33 |
| Cencora (COR) | United States | $44.832B | 17.48 |
| DiDi Global (DIDIY) | China | $24.983B | 0.00 |
| ICON (ICLR) | Ireland | $24.837B | 23.45 |
| Avantor (AVTR) | United States | $16.520B | 24.32 |
| Viatris (VTRS) | United States | $13.812B | 3.97 |
| CochLear (CHEOY) | Australia | $13.622B | 0.00 |
| Revvity (RVTY) | United States | $12.486B | 21.88 |
| Medpace Holdings (MEDP) | United States | $12.117B | 39.86 |
| Charles River Laboratories (CRL) | United States | $11.842B | 21.59 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.592B | 0.00 |
| Natera (NTRA) | United States | $11.317B | 0.00 |
| Solventum (SOLV) | United States | $11.238B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| HealthEquity (HQY) | United States | $6.843B | 51.12 |
| Organon (OGN) | United States | $5.015B | 4.76 |
| Bausch + Lomb (BLCO) | Canada | $4.870B | 19.52 |
| Doximity (DOCS) | United States | $4.537B | 33.78 |
| PACS (PACS) | United States | $3.752B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.178B | 29.41 |
| Sotera Health (SHC) | United States | $3.088B | 15.15 |
| Progyny (PGNY) | United States | $3.082B | 51.73 |
| Life Times (LTH) | United States | $2.779B | 29.44 |
| GoodRx Holdings (GDRX) | United States | $2.769B | 140.20 |
| Premier (PINC) | United States | $2.543B | 9.31 |
| AMN Healthcare Services Inc (AMN) | United States | $2.281B | 7.38 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.893B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.527B | 0.00 |
| Agiliti (AGTI) | United States | $1.369B | 22.36 |
| Establishment Labs Holdings (ESTA) | $1.359B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.003B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.766B | 7.93 |
| Embecta (EMBC) | United States | $0.589B | 3.89 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.511B | 0.00 |
| LifeMD (LFMD) | United States | $0.511B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.508B | 0.00 |
| Enhabit (EHAB) | United States | $0.501B | 45.41 |
| Auna S.A (AUNA) | Luxembourg | $0.500B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| MultiPlan (MPLN) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.399B | 0.00 |
| DocGo (DCGO) | United States | $0.366B | 58.50 |
| Sera Prognostics (SERA) | United States | $0.345B | 0.00 |
| ModivCare (MODV) | United States | $0.312B | 5.85 |
| Sharecare (SHCR) | United States | $0.269B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.150B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.072B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.037B | 0.00 |
| Nutex Health (NUTX) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |